Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations

By Hagen Anne   Bofin Anna   Ytterhus Borgny   Maehle Lovise   Kjellevold Kjell   Myhre Hans   Møller Pål   Lønning Per  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 199-203

Informa Healthcare

Access to resources Recommend Favorite

Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients

By Ferraldeschi Roberta  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1191-1198

Springer Publishing Company

Access to resources Recommend Favorite

A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes

By Musolino Antonino  

Breast Cancer Research and Treatment, Vol. 91, Iss. 2, 2005-05 ,pp. : 203-205

Springer Publishing Company

Access to resources Recommend Favorite

Germline Mutations of theBRCA1andBRCA2Genes in a Breast and Ovarian Cancer Patient

By Randall T.C.   Bell K.A.   Rebane B.A.   Rubin S.C.   Boyd J.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 432-434

Elsevier

Access to resources Recommend Favorite

The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

By Kaufman Bella  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 521-527

Springer Publishing Company

Access to resources Recommend Favorite